Go Pro

This company recently went public with an IPO on Friday, August 7th 2026. They issued 19,200,000 shares at $16.00 - $18.00 per share. We will continue to update data for LTGO as it becomes available.

Latigo Biotherapeutics (LTGO) Insider Trading & Ownership

$18.56 +0.31 (+1.70%)
As of 04:00 PM Eastern

Latigo Biotherapeutics (NASDAQ:LTGO) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$5.04M
Number Of
Insiders Selling
(Last 12 Months)
0
Get LTGO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Latigo Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LTGO Insider Buying and Selling by Quarter

Latigo Biotherapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/10/2026
Foresite Capital Management V,
Major Shareholder
Buy140,000$18.00$2,520,000.00  
8/10/2026
James B Tananbaum
Director
Buy140,000$18.00$2,520,000.00  
(Data available from 1/1/2013 forward)

LTGO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Latigo Biotherapeutics includes Foresite Capital Management V,, and James B Tananbaum. Learn more on insiders at LTGO.

The following insiders have purchased LTGO shares in the last 24 months: Foresite Capital Management V, ($2,520,000.00), and James B Tananbaum ($2,520,000.00).

Insiders have purchased a total of 280,000 LTGO shares in the last 24 months for a total of $5,040,000.00 bought.



This page (NASDAQ:LTGO) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners